Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPAREL for postsurgical analgesia in lower abdominal surgeries
NCT01919190Phase 4Terminated
- Sponsor
- Pacira BioSciences
- Start
- Aug 2013
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in Persistent postsurgical pain (PPSP) comparing EXPAREL with Placebo (2 arms). Primary endpoints: Total Opioid Consumption Post Surgery (Cumulative Total) Until Discharge Readiness or Post Surgery Day 4 and Overall Benefit of Analgesic Score at Day 3. Started Aug 2013; status: terminated.
02
Drugs
liposomal bupivacaine
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on NCT01919190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01919190.